Literature DB >> 2371927

Reliability of current techniques for histamine determination in human plasma: the European external quality control study 1988.

E Neugebauer1, J Keyzer, E Oosting, W Lorenz.   

Abstract

The increasing importance of measuring histamine in many clinical conditions and the variety of currently used techniques enforced us to organize an external quality control study (ring study) on the reliability of histamine measurements in European laboratories. Three plasma quality control samples in duplicate (lyophilized) with different amounts of histamine (0-5 ng/ml), two different aqueous histamine standard samples and one solvent sample were sent to 10 laboratories for analysis of their histamine content. The following methods were used: gas chromatographic-mass-spectrometric technique (n = 2), single isotope assay (n = 1), fluorometric-fluoroenzymatic assay (n = 3), radioimmunoassay (n = 3), HPLC technique (n = 2). The study was performed and evaluated according to the approved recommendation (1983) of the International Federation of Clinical Chemistry (IFCC). This first report of the study is concentrated on the imprecision and inaccuracy of the different principal methods and laboratories by comparing two unrelated plasma histamine samples of different analyte concentrations (target values and SD: 4.39 +/- 0.51 ng/ml and 0.99 +/- 0.17 ng/ml). This study showed a fairly good agreement between most participants. 7/11 results obtained with 4 different methods were accurate and precise in the plasma range of histamine (Youden plot). Results outside the borderlines turned out to be a problem of the analyst rather than the method itself. It is suggested to define reference values for plasma histamine and to establish reference laboratories and methods according to the IFCC-guidelines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2371927     DOI: 10.1007/bf01969059

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  8 in total

Review 1.  H1 and H2 blockade: a prophylactic principle in anesthesia and surgery against histamine-release responses of any degree of severity: Part 1.

Authors:  W Lorenz; A Doenicke
Journal:  N Engl Reg Allergy Proc       Date:  1985

2.  A graphic display of interlaboratory test results.

Authors:  L P Skendzel; W J Youden
Journal:  Am J Clin Pathol       Date:  1969-02       Impact factor: 2.493

3.  Approved recommendation (1983) on quality control in clinical chemistry. Part 3. External quality control.

Authors:  J Büttner; R Borth; J H Boutwell; P M Broughton; R C Bowyer
Journal:  J Clin Chem Clin Biochem       Date:  1983-12

4.  Measurement of plasma histamine by stable isotope dilution gas chromatography-mass spectrometry: methodology and normal values.

Authors:  J J Keyzer; B G Wolthers; F A Muskiet; H Breukelman; H F Kauffman; K de Vries
Journal:  Anal Biochem       Date:  1984-06       Impact factor: 3.365

5.  International Federation of Clinical Chemistry. Committee on Standards. Expert Panel on Nomenclature and Principles of Quality Control in Clinical Chemistry. Approved recommendation (1978) on quality control in clinical chemistry. Part 1. General principles and terminology.

Authors:  J Büttner; R Borth; J H Boutwell; P M Broughton; R C Bowyer
Journal:  Clin Chim Acta       Date:  1979-10-15       Impact factor: 3.786

6.  Histamine metabolism after adverse reactions due to d-tubocurarine administration.

Authors:  E Oosting; F J Richardson; J J Keyzer; B G Wolthers; S Agoston; D Langrehr
Journal:  Agents Actions       Date:  1987-06

7.  Reliability and practicability of the fluorometric-fluoroenzymatic histamine determination in pathogenetic studies on peptic ulcer: detection limits and problems with specificity.

Authors:  W Lorenz; K Thon; E Neugebauer; H Stöltzing; C Ohmann; D Weber; A Schmal; E Hinterlang; H Barth; J Kusche
Journal:  Agents Actions       Date:  1987-06

8.  Measurement of histamine: a quality control study.

Authors:  G J Gleich; W M Hull
Journal:  J Allergy Clin Immunol       Date:  1980-10       Impact factor: 10.793

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.